Clay Dudek is currently serving as an Associate Director at Vaniam Group, leading the development of market access and pricing service offerings for pharmaceutical clients. With a background in Life Sciences Strategy Consulting at companies like Clarivate and Decision Resources Group, as well as experience at Pfizer in research and medical affairs, Clay brings a wealth of knowledge to their current role. Additionally, Clay has a strong academic background with a Bachelor of Science in Biochemistry and ongoing education in Drug Commercialization. Outside of work, Clay has been involved in coaching soccer and working as a golf caddy at various organizations.
November, 2022 - present
September, 2021